CAS: 1346546-69-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | N-(1,3-benzothiazol-5-yl)-6-(propane-2-sulfonyl)-1,4-dihydroquinolin-4-imine REF: IN-DA01BDXKCAS: 1346546-69-7 | % | To inquire | Wed 11 Dec 24 |
 | GSK-872 REF: TM-T4074CAS: 1346546-69-7 | 99.3% | 38.00 €~1,140.00 € | Mon 16 Dec 24 |
 | GSK 872 REF: 3D-BG166846CAS: 1346546-69-7 | Min. 95% | To inquire | Wed 22 Jan 25 |
N-(1,3-benzothiazol-5-yl)-6-(propane-2-sulfonyl)-1,4-dihydroquinolin-4-imine
CAS:1346546-69-7
Formula:
C19H17N3O2S2
Purity:
%
Color and Shape:
Solid
Molecular weight:
383.4872
Ref: IN-DA01BDXK
| 1mg | 56.00 € | ||
| 5mg | 98.00 € | ||
| 10mg | 120.00 € | ||
| 25mg | 145.00 € | ||
| 50mg | 243.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
GSK-872
CAS:1346546-69-7
GSK-872 (GSK2399872A) is an effective and specific RIP3 kinase inhibitor. It binds RIP3 kinase domain …
Formula:
C19H17N3O2S2
Purity:
99.3%
Color and Shape:
Solid
Molecular weight:
383.49
Ref: TM-T4074
| 1mg | 38.00 € | ||
| 2mg | 49.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 184.00 € | ||
| 50mg | 347.00 € | ||
| 100mg | 517.00 € | ||
| 500mg | 1,140.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
GSK 872
CAS:1346546-69-7
Inhibitor of RIPK3 kinase
Formula:
C19H17N3O2S2
Purity:
Min. 95%
Molecular weight:
383.49 g/mol
Ref: 3D-BG166846
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
